Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0232605 (
regurgitation
)
8,217
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Almost 90% of children with congenital heart disease now reach adulthood due to the improved results of cardiac surgery and medical treatment. Among them, one of particular problems is pulmonary valve
regurgitation
after tetralogy of Fallot repair. About 20 years ago (1996), the mortality of tetralogy of Fallot has already been relatively good at about 5%, but now it is further reduced to about 2%. For this reason, it is conceivable that more and more adult patients with tetralogy of Fallot will increase in the future.
Pulmonary valve regurgitation
is often caused by the use of transannular patch repair. Surgical indications for pulmonary valve
regurgitation
include those with decreased exercise tolerance, right ventricular dysfunction, advanced right ventricular enlargement. We examined treatment strategies, valve selection and catheter valve implantation.
...
PMID:[Surgical Management of the Patients with Tetralogy of Fallot; Long-term after Initial Repair]. 3126 10
Pulmonary regurgitation
is the most important sequellae after correction of Tetralogy of Fallot and has a considerable impact over the right ventricle. Surgery has demonstrated low early mortality after pulmonary valve replacement and good long-term outcomes, remaining nowadays the gold standard treatment of pulmonary
regurgitation
in rTOF patients. Nevertheless, transcatheter pulmonary valve implantation has emerged as a new, safe and efficient alternative to surgical valve replacement. In this review article, we try to evaluate and compare both techniques to find out which is the best therapeutic option in this patients.
...
PMID:Pulmonary regurgitation after repaired tetralogy of Fallot: surgical versus percutaneous treatment. 3295 67
<< Previous
1
2
3
4
5
6
7